The global artificial intelligence in drug discovery market size is estimated at USD 9.1 billion in 2030, and is expected to expand at a CAGR of 29.7% from 2024 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The...